Status:
COMPLETED
Plaque Psoriasis Study in Pediatric Subjects
Lead Sponsor:
Galderma R&D
Conditions:
Plaque Psoriasis
Eligibility:
All Genders
2-12 years
Phase:
PHASE4
Brief Summary
The purpose of this study is to compare the safety, efficacy and calcium metabolism of up to 8 weeks of treatment with calcitriol 3 mcg/g ointment versus its vehicle, when used twice daily, without oc...
Eligibility Criteria
Inclusion
- Male or female 2 to 12 years of age
- Clinical diagnosis of stable mild to moderate plaque psoriasis
Exclusion
- Other forms of psoriasis
- Hypercalcemia
- Past history of kidney stones
- Vitamin D deficiency
- Other concomitant dermatological disease
Key Trial Info
Start Date :
July 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2016
Estimated Enrollment :
19 Patients enrolled
Trial Details
Trial ID
NCT02186665
Start Date
July 1 2014
End Date
January 1 2016
Last Update
February 18 2021
Active Locations (34)
Enter a location and click search to find clinical trials sorted by distance.
1
David Stoll, MD
Beverly Hills, California, United States, 90212
2
Center for Dermatology and Laser Surgery
Sacramento, California, United States, 95819
3
Dermatology Specialists Research
Louisville, Kentucky, United States, 40202
4
University of Mississippi Medical Center
Jackson, Mississippi, United States, 39216